along with giving DGEN royalty rights on top of the 25 million for any drugs commercialized from the data, and the mice were extra. The major deal that mgmt pulled off to pull the company out of bk was a multi-million deal with the NIH and the Wellcome-Trust whereby mice and the database were made available to academic institutions on a royalty free basis - but royalty rights were retained for any commercial development of any academic development. Run Deltagen through the US Patent Office database - they hold dozens. Hundreds more were in the application process pipeline but had to be abandoned as the legal fees for patent perfection were not sustainable - another proper call by mgmt. All to say, this company has been an absolute steal at a nickel.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM